- Home
- SXTC vs HPS Comparison
SXTC vs HPS Comparison
Compare SXTC & HPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTC
- HPS
- Stock Information
- Founded
- SXTC 2005
- HPS 2003
- Country
- SXTC China
- HPS United States
- Employees
- SXTC N/A
- HPS N/A
- Industry
- SXTC Biotechnology: Pharmaceutical Preparations
- HPS Investment Managers
- Sector
- SXTC Health Care
- HPS Finance
- Exchange
- SXTC Nasdaq
- HPS Nasdaq
- Market Cap
- SXTC 2.5M
- HPS 547.0M
- IPO Year
- SXTC 2019
- HPS N/A
- Fundamental
- Price
- SXTC $0.57
- HPS $17.02
- Analyst Decision
- SXTC
- HPS
- Analyst Count
- SXTC 0
- HPS 0
- Target Price
- SXTC N/A
- HPS N/A
- AVG Volume (30 Days)
- SXTC 696.2K
- HPS 58.4K
- Earning Date
- SXTC 01-01-0001
- HPS 01-01-0001
- Dividend Yield
- SXTC N/A
- HPS 8.62%
- EPS Growth
- SXTC N/A
- HPS N/A
- EPS
- SXTC N/A
- HPS N/A
- Revenue
- SXTC $1,928,497.00
- HPS N/A
- Revenue This Year
- SXTC N/A
- HPS N/A
- Revenue Next Year
- SXTC N/A
- HPS N/A
- P/E Ratio
- SXTC N/A
- HPS N/A
- Revenue Growth
- SXTC N/A
- HPS N/A
- 52 Week Low
- SXTC $0.53
- HPS $11.79
- 52 Week High
- SXTC $6.39
- HPS $15.40
- Technical
- Relative Strength Index (RSI)
- SXTC 39.07
- HPS 64.69
- Support Level
- SXTC $0.67
- HPS $17.02
- Resistance Level
- SXTC $0.75
- HPS $17.25
- Average True Range (ATR)
- SXTC 0.09
- HPS 0.14
- MACD
- SXTC -0.00
- HPS -0.01
- Stochastic Oscillator
- SXTC 8.96
- HPS 72.81
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About HPS John Hancock Preferred Income Fund III Preferred Income Fund III
John Hancock Preferred Income Fund III is a closed-end, diversified management investment company. Its investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve the objectives by investing a majority of its assets in preferred stocks and other preferred securities, including convertible preferred securities. The portfolio composition of the company consists of the U.S. preferred securities, foreign preferred securities, common stocks, corporate bonds, and the short-term investments.